L
Leslee J. Shaw
Researcher at Cornell University
Publications - 871
Citations - 70793
Leslee J. Shaw is an academic researcher from Cornell University. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 116, co-authored 808 publications receiving 61598 citations. Previous affiliations of Leslee J. Shaw include Saint Louis University & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Prognostic Assessment of Coronary Artery Bypass Patients With 64-Slice Computed Tomography Angiography: Anatomical Information Is Incremental to Clinical Risk Prediction
Gary R. Small,Yeung Yam,Li Chen,Osman Ahmed,Mouaz H. Al-Mallah,Daniel S. Berman,Victor Y. Cheng,Kavitha Chinnaiyan,Gilbert L. Raff,Todd C. Villines,Stephan Achenbach,Matthew J. Budoff,Filippo Cademartiri,Tracy Q. Callister,Hyuk Jae Chang,Augustin Delago,Allison Dunning,Martin Hadamitzky,Jörg Hausleiter,Philipp A. Kaufmann,Philipp A. Kaufmann,Fay Y. Lin,Erica Maffei,James K. Min,Leslee J. Shaw,Benjamin J.W. Chow +25 more
TL;DR: Coronary computed tomography angiography provides incremental anatomical data to clinical risk assessment to help determine the prognosis of patients after CABG to help identify those patients at highest risk.
Journal ArticleDOI
Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy
Cesar A. Santana,Leslee J. Shaw,Ernest V. Garcia,Marina Soler-Peter,Jaume Candell-Riera,Gabriel B. Grossman,Elizabeth G. Krawczynska,Tracy L. Faber,Aida Ribera,Viola Vaccarino,Raghuveer Halkar,Marcelo F. Di Carli +11 more
TL;DR: LV functional parameters determined by gated FDG PET have incremental prognostic value over viability information in patients with ischemic cardiomyopathy, and data suggest that patients with residual viability and advanced cardiac remodeling are at high clinical risk.
Journal ArticleDOI
Proceedings from the Scientific Symposium: Sex Differences in Cardiovascular Disease and Implications for Therapies
C. Noel Bairey Merz,Saralyn Mark,Barbara D. Boyan,Alice K. Jacobs,Prediman K. Shah,Leslee J. Shaw,Doris A. Taylor,Eduardo Marbán +7 more
TL;DR: CVD repair strategies should ideally be tested first in females to have the best chance of success for proof-of-concept, and sex-specific pharmacogenomic studies should be included in pharmacological development.
Journal ArticleDOI
Tracking atherosclerosis regression: a clinical tool in preventive cardiology.
Allen J. Taylor,Leslee J. Shaw,Zahi A. Fayad,Daniel H. O'Leary,B. Greg Brown,Steven E. Nissen,Daniel J. Rader,Paolo Raggi +7 more
TL;DR: Athrosclerosis imaging modalities such as coronary computed tomography, carotid ultrasound, cardiovascular magnetic resonance imaging, and intravascular ultrasound each possess specific imaging abilities and inter-test characteristics that enable their serial use as intermediate endpoints in clinical trials and, increasingly, in individual patient management.
Journal ArticleDOI
Impact of Coronary Artery Calcium Progression and Statin Therapy on Clinical Outcome in Subjects With and Without Diabetes Mellitus
Sarkis Kiramijyan,Naser Ahmadi,Hussain Isma'eel,Ferdinand Flores,Leslee J. Shaw,Paolo Raggi,Matthew J. Budoff +6 more
TL;DR: CAC progression was greater and event-free survival lower in patients with DM compared to controls in proportion to the extent of CAC progression, suggesting that CAC progressions is an independent predictor of all-cause mortality in subjects with diabetes mellitus.